Journal of Turkish Clinical Biochemistry

The official publication of Turkish Society of Clinical Biochemistry

Diamond OA
No APCs
First Decision
30 Days
Indexed In
TR Dizin
Original Research
August 01, 2021
JTCB. 2021 Aug 1; 19 (2) : 159-164
79 85
PDF

Oral Glucose Tolerance Test: who gives information and is it sufficient?

1 Sağlık Bilimleri Üniversitesi İzmir Bozyaka Eğitim ve Araştırma Hastanesi, Tıbbi Biyokimya, İzmir, Türkiye

Abstract

Purpose: Oral glucose tolerance test (OGTT) is a very important procedure in diagnosing diabetes mellitus. It is very crucial to perform OGTT according to the rules that must be taken into account in preparation period of the test. Our aim was to determine the level of awareness and the source of information among the patients about the OGTT procedure.

Materials and Methods: The 680 outpatients, who were sent to the laboratory for OGTT, were asked to answer the questions reflecting the level of knowledge about OGTT. The data related to the answers to the questions were presented as numbers and ratios. Statistical analysis was made by chi square test.

Results: Only 160 (23.5%) of patients declared that they have got information about OGTT. The source of knowledge was mostly their clinicians 425 (62.5%) and the laboratory staff 255 (37.5%). According to the declaration of patients that they got information or not there was a statistically significant difference with the education level (p<0.05).

Conclusion: Although giving information to patients is the responsibility of the clinicians, the laboratory staff should try to understand if the patients are well informed or not, when giving OGTT appointment to the patients in order to complement insufficient information.

Citation

Bilgili, Sibel, Özge Fenercioğlu, Gizem Ercan, and Giray Bozkaya. 2021. “Oral Glucose Tolerance Test: Who Gives Information and Is It Sufficient?”. Journal of Turkish Clinical Biochemistry 19 (2):159-64. https://turkclinbiochem.org/index.php/pub/article/view/399.

Publish with JTCB

Diamond Open Access

Fully Diamond OA with no APCs and no submission fees. Your research is freely available to readers worldwide from the day it publishes.

30-Day First Decision

Double-blind peer review from an active editorial team returns a first decision in about 30 days, keeping your manuscript moving.

Global Platform

Backed by the Turkish Society of Clinical Biochemistry, JTCB welcomes submissions from researchers worldwide and reaches an international laboratory audience.

Focused Laboratory Scope

Method validation, analyzer comparisons, reference intervals, quality indicators, preanalytical studies, and instructive clinical case reports.

Credible and Discoverable

All manuscripts publish in English and follow ICMJE and COPE guidelines, with Crossref DOIs and TR Dizin indexing ensuring global discoverability.